Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure

Published 2013 View Full Article

Authors

Keywords

Journal

AMERICAN HEART JOURNAL

Volume 166, Issue 4, Pages 654-661.e6

Publisher

Elsevier BV

Online

2013-09-17

DOI

10.1016/j.ahj.2013.06.024

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

AMERICAN HEART JOURNAL

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Find the ideal target journal for your manuscript